The first Sunday in June is National Cancer Survivors Day — an annual moment to recognise the growing community of women living well after a gynaecological cancer diagnosis. Below are five lessons drawn from long-term survivors I have followed in my practice over the past decade.
On this page
- Lesson 1: Surgical completeness is non-negotiable
- Lesson 2: Maintenance therapy quietly changes outcomes
- Lesson 3: BRCA testing is for living, not just diagnosis
- Lesson 4: Surveillance fatigue is real — and dangerous
- Lesson 5: Survivorship is a relationship, not a date
Lesson 1: Surgical completeness is non-negotiable
The single strongest predictor of long-term ovarian cancer survival is achieving complete cytoreduction (no visible residual disease) at primary surgery. Survivors who later thrive almost always had CC-0 or CC-1 resection by a fellowship-trained surgical team. Volume of cases matters — both the surgeon’s and the centre’s.
Lesson 2: Maintenance therapy quietly changes outcomes
The introduction of PARP inhibitor maintenance (olaparib, niraparib, rucaparib) has changed survival profiles for BRCA-mutated and HRD-positive ovarian cancer. Many long-term survivors started maintenance therapy after first-line completion and have maintained remission for years.
Lesson 3: BRCA testing is for living, not just diagnosis
BRCA1/2 testing is not just about treatment decisions. It identifies your daughter’s, sister’s and niece’s risk too. Several long-term survivors I follow have used their result to organise family screening — and prevented cancer in relatives.
Lesson 4: Surveillance fatigue is real — and dangerous
Around year 3–4 of surveillance, energy and attention dip. Patients miss CA-125 tests. They skip 6-monthly reviews. The survivors who do best are the ones who treat surveillance like a 5-year contract, not an optional habit.
Lesson 5: Survivorship is a relationship, not a date
The 5-year mark is a statistical milestone, not a finish line. Long-term survivors maintain a working relationship with their oncologist for symptoms, late effects, and second opinions on adjacent decisions (hormone replacement, bone health, sexual function). Survivorship care is medicine; not just memory.
What to do
If you are a survivor approaching the 5-year mark, or a family member of a survivor, book a survivorship review with Dr. Nishtha. WhatsApp +91 76988 00333.
External: National Cancer Institute Ovarian Cancer Guide. See also our recurrent disease treatment page.
FAQs
What counts as a 'long-term' ovarian cancer survivor?
Generally, 5+ years from diagnosis without active disease. For advanced-stage diagnoses, even 3-year disease-free intervals are clinically meaningful and worth marking.
Do all ovarian cancer patients need lifelong follow-up?
Active surveillance is intensive for the first 5 years (3-monthly), then 6-monthly to year 10, then annual review. Late recurrences do happen and warrant ongoing vigilance.
Is PARP maintenance available in India?
Olaparib, niraparib and rucaparib are available in India. Cost varies; insurance coverage is improving but pre-authorisation is required for most policies.
What is a 'survivorship clinic'?
A combined service that addresses cancer follow-up plus the long-term effects of treatment — fatigue, bone health, sexual function, second-cancer screening. Increasingly important as more women live decades after diagnosis.
Can I bring a family member for BRCA testing the same day?
Yes. We routinely test affected patients first; if BRCA-positive, family members are then offered cascade testing. The hospital genetics counsellor coordinates the family discussion.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. For consultations: WhatsApp +91 76988 00333.